Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-02-09 @ 2:58 AM
Study NCT ID:
NCT01234402
Status:
COMPLETED
Last Update Posted:
2019-08-14
First Post:
2010-11-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer Patients
Sponsor:
Eli Lilly and Company
Organization: